Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4,6-pyrimidinediones

European Journal of Medicinal Chemistry

Volumn 45, Issue 4, 2010, Pages 1667-1672

  Tomašić, Tihomir ^a   Zidar, Nace ^a   Mueller Premru, Manica ^a   Kikelj, Danijel ^a   Mašič, Lucija Peterlin ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Antibacterial agents; Knoevenagel condensation; Rhodanine; Thiazolidin 4 one

Indexed keywords

2 [4 OXO 2 THIOXO 5 (2,3,4 TRIFLUOROBENZYLIDENE)THIAZOLIDIN 3 YL]ACETID ACID; 2 [4 OXO 2 THIOXO 5 (3,4,5 TRIMETHOXYBENZYLIDENE)THIAZOLIDIN 3 YL]ACETID ACID; 2 THIOXO 5 (2,3,4 TRIFLUOROBENZYLIDENE)THIAZOLIDIN 4 ONE; 2 THIOXO 5 (3,4,5 TRIMETHOXYBENZYLIDENE)DIHYDROPYRIMIDINE 4,6(1H,5H) DIONE; 2 THIOXO 5 (3,4,5 TRIMETHOXYBENZYLIDENE)THIAZOLIDIN 4 ONE; 5 (2,3,4 TRIFLUOROBENZYLIDENE)PYRIMIDINE 2,4,6(1H,3H,5H) TRIONE; 5 (2,3,4 TRIFLUOROBENZYLIDENE)THIAZOLIDINE 2,4 DIONE; 5 (3,4,5 TRIMETHOXYBENZYLIDENE)PYRIMIDINE 2,4,6(1H,3H,5H) TRIONE; 5 (3,4,5 TRIMETHOXYBENZYLIDENE)THIAZOLIDINE 2,4 DIONE; ANTIINFECTIVE AGENT; BENZYLIDENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; BACTERIA; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, INFRARED; THIAZOLIDINES;

EID: 77349086596     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.12.030     Document Type: Article

References (25)

1. Chopra I., Schofield C., Everett M., O'Neill A., Miller K., Wilcox M., Frère J.-M., Dawson M., Czaplewski L., Urleb U., and Courvalin P. Lancet Infect. Dis. 8 (2008) 133-139
2. Terashima H., Hama K., Yamamoto R., Tsuboshima M., Kikkawa R., Hatanaka I., and Shigeta Y. J. Pharmacol. Exp. Ther. 229 (1984) 226-230
3. Yoshioka T., Fujita T., Kanai T., Aizawa Y., Kurumada T., Hasegawa K., and Horikoshi H. J. Med. Chem. 32 (1989) 421-428
4. Tomašić T., and Mašič L.P. Curr. Med. Chem. 16 (2009) 1596-1629
5. Vicini P., Geronikaki A., Anastasia K., Incerti M., and Zani F. Bioorg. Med. Chem. 14 (2006) 3859-3864
6. Albrecht U., Gördes D., Schmidt E., Thurow K., Lalk M., and Langer P. Bioorg. Med. Chem. 13 (2005) 4402-4407
7. Bozdaǧ-Dündar O., Özgen O., Menteşe A., Altanlar N., Atli{dotless} O., Kendi E., and Ertan R. Bioorg. Med. Chem. 15 (2007) 6012-6017
8. Gouveia F.L., de Oliveira R.M.B., de Oliveira T.B., da Silva I.M., do Nascimento S.C., de Sena K.X.F.R., and de Albuquerque J.F.C. Eur. J. Med. Chem. 44 (2009) 2038-2043
9. Tomašić T., Zidar N., Rupnik V., Kovač A., Blanot D., Gobec S., Kikelj D., and Mašič L.P. Bioorg. Med. Chem. Lett. 19 (2009) 153-157
10. Šink R., Kovač A., Tomašić T., Rupnik V., Boniface A., Bostock J., Chopra I., Blanot D., Mašič L.P., Gobec S., and Zega A. ChemMedChem 3 (2008) 1362-1370
11. Mueller-Premru M., Zidar N., špik V.C., Krope A., and Kikelj D. Chemotherapy 55 (2009) 414-417
12. T. Tomašić, N. Zidar, A. Kovač, S. Turk, M. Simčič, D. Blanot, M. Mueller-Premru, M. Filipič, S.G. Grdadolnik, A. Zega, M. Anderluh, S. Gobec, D. Kikelj, L.P, Mašič, ChemMedChem. in press, doi:10.1002/cmdc.200900449.
13. T. Tomašić, A. Kovač, unpublished results.
14. Zidar N., Kladnik J., and Kikelj D. Acta Chim. Slov. 56 (2009) 635-642
15. Ishida T., In Y., Inoue M., Ueno Y., Tanaka C., and Hamanaka N. Tetrahedron Lett. 30 (1989) 959-962
16. Momose Y., Meguro K., Ikeda H., Hatanaka C., Oi S., and Sohda T. Chem. Pharm. Bull. 39 (1991) 1440-1445
17. Barreteau H., Kovač A., Boniface A., Sova M., Gobec S., and Blanot D. FEMS Microbiol. Rev. 32 (2008) 168-207
18. c Log P values were calculated by ChemBio3D Ultra 11.0 from ChemBioOffice 2008 available from CambridgeSoft (2008).
19. Hilliard J.J., Goldschmidt R.M., Licata L., Baum E.Z., and Bush K. Antimicrob. Agents Chemother. 43 (1999) 1693-1699
20. R. Frechette, M. Weidner-Wells, PCT patent application WO 97/17333, 1997. Chem. Abstr. 127 (1997) 50652.
21. Campaigne E., and Kreighbaum W.E. J. Org. Chem. 26 (1961) 1326-1327
22. Sachan N., Kadam S.S., and Kulkarni V.M. Indian J. Heterocycl. Chem. 17 (2007) 57-62
23. Amsterdam D. In: Lorian V. (Ed). Antibiotics In Laboratory Medicine (1996), Williams and Wilkins, Baltimore 92-111
24. Barry A.L., Reller L.B., Miller G.H., Washington J.A., Schoenknect F.D., Peterson L.R., Hare R.S., and Knapp C. J. Clin. Microbiol. 30 (1992) 585-589
25. Clinical Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; Eighteenth Informational Supplement (2008) pp. 1-181.